Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share

457
The Lancet®

Last Loaded on Web: Wednesday, May 01, 2013

Last Update To Bluesheet: April 1, 2009

Bluesheet Contents     PDF version

File Description Print Counterparts Special Features Sample Record Sort
Subject Coverage Dialog File Data DIALINDEX/OneSearch Categories Basic Index Rank
Sources Document Types Indexed Contact Additional Indexes Predefined Format Options
Tips Geographic Coverage Terms and Conditions Limit Rates


File Description [top]

The Lancet® contains full-text articles from the weekly general medical journal, The Lancet. The Lancet's goal is to advance or illuminate medical science and practice. Coverage extends to all aspects of human health.

Known for its independent, authoritative voice in global medicine, its publishing history includes reports on numerous medical breakthroughs in the last 200 years, including shell shock therapy, penicillin, and birth defects to more recent medical advancements such as the description of a new variant of Creutzfeldt-Jakob disease and the identification of coronavirus as a possible cause of SARS. The Lancet was the first journal to carry a reference to the Ebola virus, and arguably the first to publish a letter from Alexander Fleming.

Before publication, papers undergo rigorous peer review and when appropriate, examination by a statistician. Approximately 40% of contributions come from Europe, 40% from the U.S., and 20% from the rest of the world. In addition to articles and short reports, The Lancet also carries news items and a substantial letters section, thus promoting lively debate of medical issues.

Published since 1823, The Lancet continues to provide physicians, researchers and journalists with an informative, critical and insightful view of medicine today.

Use File 457 to answer such questions as:^

What are the effects of grapefruit juice on cyclosporin?^

How are opioid antagonists used in Tourette's syndrome?^

What are the risks of relapse in multibacillary leprosy?^

Are there any successful health insurance schemes in rural Africa?^

How does medical treatment compare with surgery for massive pulmonary embolism?



Tips [top]

USE File 457

to find current, authoritative medical information

EXPAND DT=

to see a complete list of document types indexed

USE a range for Word Count

S WD=2000:5000



Subject Coverage [top]

The Lancet is a multi-specialty and cross-disciplinary file that covers issues relevant to both industrialized and non-industrialized countries.



Sources [top]

The Lancet contains the fulltext of all articles published in The Lancet, and in The Lancet Neurology, The Lancet Infectious Diseases, and The Lancet Oncology. A two-month embargo means that articles appear online two months after their appearance in the hard copy.

The articles' tables, illustrations, photographs and other graphical material may be viewed by following links in records to ProQuest's collection of 'text plus graphics' and full page images.



Print Counterparts [top]

  • The Lancet
  • The Lancet Infectious Diseases
  • The Lancet Neurology
  • Lancet Oncology


Dialog File Data [top]

Dates Covered: The Lancet: from 1992; The Lancet Infectious Diseases: from 2001; The Lancet Neurology: from 2002; The Lancet Oncology: from 2000
File Size: More than 62,000 records as of November 2009
Update Frequency: Weekly


Document Types Indexed [top]

  • Journal articles, book reviews


Geographic Coverage [top]

  • International


Geographic Restrictions [top]

  • None


Special Features [top]


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
BIOSCI Biosciences
HEALTH Health
MAGSALL Journals and Magazines
MAGTEXT Full-Text Journals and Magazines
MEDDEV Medical Devices
MEDENG Medical Engineering
MEDICINE Medicine
MEDTEXT Fulltext Medical Journal Files
NUTRIT Nutrition
SAFETY Safety


Contact [top]

The Lancet is produced by Elsevier. Questions concerning file content should be directed to:

Elsevier Limited
1600 John F. Kennedy Boulevard, Suite 1800
Philadelphia, PA 19103-2899
sarah.ramsay@lancet.com


Terms and Conditions [top]

The Lancet(c) is a registered trademark of Elsevier Properties, S.A., used under license.

Database copyrighted by Elsevier Limited. For Dialog's Redistribution and Archive Policy enter HELP ERA online.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    DIALOG(R)File 457: THE LANCET 199202998/Apr W3 
    ©2009 Elsevier Limited. All rts reserv. 
     
    0000070575   1662930331 
  /TI  Measles in Europe: an epidemiological assessment 
     
  AU=  Muscat, Mark; Bang, Henrik; Wohlfahrt, Jan; Glismann, Steffen; Molbak, Kare 
  JN=,SO=,PD=,PY=  The Lancet  vol. 373 , 9661  PP: 383-389   Jan 31-Feb 6, 2009 
  CD=,DT=,SN=,JC=,LA=,RT=  CODEN: LANCAO   Document Type: PERIODICAL; Feature   ISSN: 0140-6736  Journal 
    Code: GLAN   Language: English   Record Type: New; Fulltext 
    Length: 7 Pages 
  WD=  Word Count: 5410 
    URL(Full Text): http://proquest.umi.com/pqdweb?userid=xxxxxxxx&passwd=yyyyyyy&did 
    =1662930331&Fmt=3&RQT=309&Vname=PQD&session=0 
    URL(Full Page Image): http://proquest.umi.com/pqdweb?userid=xxxxxxxx&passwd=yyyyyy&did 
    =1662930331&Fmt=6&RQT=309&Vname=PQD&session=0 
  /AB  Abstract: 
     
       Measles persists in Europe despite the incorporation of the measles vaccine 
    into routine childhood vaccination programmes more than 20 years ago. Our 
    aim was therefore to review the epidemiology of measles in relation to the 
    goal of elimination by 2010. National surveillance institutions from 32 
    European countries submitted data for 2006-07. Data for age-group, 
    diagnosis confirmation, vaccination, hospital treatment, the presence of 
    acute encephalitis as a complication of disease, and death were obtained. 
    30 countries also supplied data about importation of disease. 
     
               (. . .) 
     
  /TX  Text:   
     Summary 
        Background Measles persists in Europe despite the incorporation of the 
    measles vaccine into routine childhood vaccination programmes more than 20 
    years ago. Our aim was therefore to review the epidemiology of measles in 
    relation to the goal of elimination by 2010. 
        Methods National surveillance institutions from 32 European countries 
    submitted data for 2006-07. Data for age-group, diagnosis confirmation, 
    vaccination, hospital treatment, the presence of acute encephalitis as a 
    complication of disease, and death were obtained. 30 countries also 
    supplied data about importation of disease. Clinical, laboratory-confirmed, 
    and epidemiologically linked cases that met the requirements for national 
    surveillance were analysed. Cases were separated by age: younger than 1 
    year, 1-4 years, 5-9 years, 10-14 years, 15-19 years, and older than 20 
    years. Countries with indigenous measles incidence per 100 000 inhabitants 
    per year of 0, less than 0?1, 0?1-1, and more than 1 were grouped into 
    categories of zero, low, moderate, and high incidence, respectively. 
        Findings For the 2 years of the study, 12 132 cases of measles were 
    recorded with most cases (n=10 329; 85%) from five countries: Romania, 
    Germany, UK, Switzerland, and Italy. Most cases were unvaccinated or 
    incompletely vaccinated children; however, almost a fifth were aged 20 
    years or older. For the same 2 years, seven measles-related deaths were 
    recorded. High measles incidence in some European countries revealed 
    suboptimum vaccination coverage. Of the 210 cases that were reported as 
    being imported, 117 (56%) came from another country within Europe and 43 
    (20%) from Asia. 
     
               (. . .) 
     
        Contributors 
        MM had primary responsibility for coordinating EUVAC.NET's measles 
    surveillance activities and analysed data, reviewed literature, and wrote 
    the report. HB gathered and validated the data, and produced the graphics. 
    JW did the statistical analysis and reviewed the report. SG and KM reviewed 
    and commented on the final version of the report. The EUVAC.NET group 
    processed and supplied national measles data, and commented on the final 
    version of the report. 
     
               (. . .) 
     
        Acknowledgments 
        We thank the following collaborators within various public health and 
    surveillance institutions: Vanya Mehandzhieva (Bulgaria); Jitka Castkova 
    and Marcela Smelhausova (Czech Republic); Ulpu Elonsalo (Finland); Theano 
    Georgakopoulou and Eleni Kalamara (Greece); Massimo De Crescenzo, Corrado 
    Cenci, and Lucia Virtuani, (Italy); Jelena Curikova (Latvia); Andrew Amato 
    Gauci (Malta), and Miroslaw P Czarkowski (Poland); Judite Catarino 
    (Portugal); Mateja Bla?ko Markie (Slovenia); Eva Maderova and Alexandra 
    Zampachova (Slovakia); Solveig Olsson (Sweden); and Kevin Brown, Claire 
    Cameron, and Mary Ramsay (UK). 
     
               (. . .) 
     
    Sidebar:     
    Lancet 2009; 373: 383-89 
        Published Online 
        January 7, 2009 
        DOI:10.1016/S0140-6736(08)61849-8 
        Panel: Top ten countries identified as a source of measles importation 
    into Europe (2006-07) 
        Number of cases (2006) 
        Ukraine (17), Thailand (13), Italy (11), Pakistan (8), India (8), 
    Romania (6), Spain (6), Germany (5), Morocco (4), Ethiopia (4) 
        Number of cases (2007) 
        Switzerland (13), UK (10), Germany (9), Spain (7), Italy (6), India 
    (5), Pakistan (4), Thailand (4), China (3), Ethiopia (3) 
     
  /CR  Cited References:     
    References 
        1 Richard JL, Masserey Spicher V. Ongoing measles outbreak in 
    Switzerland: results from November 2006 to July 2007. Euro Surveill 2007; 
    12: E070726.1. 
        2 Bernard H, Fischer R, Wildner M. Ongoing measles outbreak in southern 
    Bavaria, Germany. Euro Surveill 2008; 13: 8002. 
        3 Torner N, Martinez A, Costa J, et al. Measles outbreak in the 
    Barcelona Region of Catalonia, Spain, October 2006 to February 2007. Euro 
    Surveill 2007; 12: E070222.2. 
        4 Kremer JR, Brown KE, Jin L, et al. High genetic diversity of measles 
    virus, World Health Organization European region, 2005-2006. Emerg Infect 
    Dis 2008; 14: 107-14. 
     
               (. . .) 
     
        40 Rota PA, Bellini WJ. Update on the global distribution of genotypes 
    of wild type measles viruses. J Infect Dis 2003; 187 (suppl 1): S270-76. 
     
    THIS IS THE FULL-TEXT. Copyright Elsevier Limited Jan 31-Feb 6, 2009 
  /DE  Descriptors: Public health; Surveillance; Data collection; Data analysis; Measles; Epidemics 
  /GN  Geographic Names: Europe 
  AV=  Print Media ID: 28154 
  SF=  Special Features: Maps; Graphs; Tables; References 
    DIALOG Update Date: 20090426; 03:27:16 EST 
     


BASIC INDEX [top]

SEARCH
SUFFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
None None All Basic Index Fields Word S VACCINATION(W)PROGRAMMES
/AB AB Abstract Word S MEASLES(W)VACCINE/AB
/CO CO Compant Name1 Word S NATIONAL(W)HEALTH(W)SERVICE/CO
/CR CR Cited References Word S EURO(W)SURVEILL(W)2007/CR
/DE DE Descriptors2 Word
& Phrase
S PUBLIC(W)HEALTH/DE
S DATA ANALYSIS/DE
/GN GN Geographic Name1 Word S EAST(W)TIMOR/GN
/NM NM Named Person1 Word S CHARLES(1N)DARWIN/NM
/TI TI Title Word S MEASLES(1W)EUROPE/TI
/TX TX Text Word S SUBOPTIMUM(1W)COVERAGE/TX

1 Searchable in the Basic Index and the Additional Indexes

2 Also /DF.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
AA= AA IP Accession Number Phrase S AA=1662930331
AU= AU Author Phrase S AU=MUSCAT, MARK?
AV= AV Print Media ID Phrase S AV=28154
None AZ DIALOG Accession Number
CD= CD CODEN Phrase S CD=LANCAO
CO= CO Company Name Phrase S CO=NATIONAL HEALTH?
CS= CS Author Affiliation Word
& Phrase
S CS=(MEASLES(1W)INITIATIVE)
S CS=MEASLES INITIATIVE
DT= DT Document Type3 Phrase S DT=PERIODICAL
GN= GN Geographic Name1 Phrase S GN=BURKINO FASO
JC= JC Journal Code Phrase S JC=GLAN
JN= JN Journal Name Phrase S JN=THE LANCET
LA= LA Language Phrase S LA=ENGLISH
NC= NC NAICS Code Phrase S NC=448310
NM= NM Named Person1 Phrase S NM=DARWIN, CHARLES
None NP Number of Pages3
PD= PD Publication Date Phrase S PD=20090131
PY= PY Publication Year Phrase S PY=2009
RT= RT Record Type Phrase S RT=FULLTEXT
SF= SF Special Feature Phrase S SF=PHOTOGRAPH
SN= SN International Standard Serial Number (ISSN) Phrase S SN=0140-6736
SO= SO Source Word S SO=(LANCET AND 373)
UD= None Update Phrase S UD=9999
None UR URL
WD= WD Word Count Numeric S WD=5400:5500

3 EXPAND DT= to see a list of document types.


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/ENG English language records S DT=REVIEW?/ENG
/FULLTEXT Fulltext records S UD=?/FULLTEXT
/NOTEXT Does not search Text field S MALARIA/NOTEXT
/YYYY Publication Year S S2/2009


SORT [top]

SORTABLE FIELDS EXAMPLES
AU, CO, CS, JC, JN, PD, PY, TI SORT S1/ALL/PY,D
PRINT S5/5/1-24/AU


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: NM RANK CS
RANK AU S4


USER-DEFINED FORMAT OPTIONS [top]

Display codes listed in the Search Options tables can be used to customize output. TYPE S3/AU,TI/1-5


PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT
RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Full record except Abstract and Text
3 Medium Bibliographic Citation
4 -- Bibliographic Citation and Abstract
5 -- Full Record except Text
6 Short Title and Publication Date
7 -- Title, Abstract, Text, and Source
8 Free Title, Publication Date, Word Count, and Indexing
9 Full Full Record
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
If the accession number of a specific record is known, it can be used to display the record directly. TYPE 070787/3
DISPLAY 070110/TI,AU
PRINT 067332/9


Rates [top]

Rates For File: The Lancet®[457]
Cost per DialUnit:                 $6.50
Cost per minute:                   $1.87
Rank Elements                      $0.00
ALERT (default)                    $3.00
ALERT (Monthly)                    $9.25
ALERT (Biweekly/twice a month) *   $5.25
ALERT (Weekly)                     $3.00
ALERT (Daily)                  *   $3.00
ALERT (Calendar weekly)        *   $3.00
ALERT (Intraday)               *   $3.00
* = custom scheduled Alerts only
ALERT Number of included prints        0

Format    Types   Prints
     1    $0.00    $0.00
     2    $3.50    $3.50
     3    $3.50    $3.50
     4    $7.00    $7.00
     5    $7.00    $7.00
     6    $0.00    $0.00
     7    $7.00    $7.00
     8    $0.00    $0.00
     9    $7.00    $7.00
KWIC95    $0.00       NA
KWIC96    $0.00       NA
[top]



All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.